pentobarbital will reduce the extent or influence of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers might lower partiaprevir and ritonavir ranges, and for that reason decreased efficacy of Vieki